Microvesicles: What is the role in multiple sclerosis?

Frontiers in Neurology

Volumn 6, Issue MAY, 2015, Pages

  Carandini, Tiziana ^a   Colombo, Federico ^a   Finardi, Annamaria ^a   Casella, Giacomo ^a   Garzetti, Livia ^a   Verderio, Claudia ^b,c   Furlan, Roberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CNR   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Biomarkers; Ectosomes; Exosomes; Horizontal communication; Microglia; Microvesicles; Multiple sclerosis

Indexed keywords

ARACHIDONIC ACID; BETA1A INTERFERON; BIOLOGICAL MARKER; CD31 ANTIGEN; FINGOLIMOD; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON BETA SERINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEMBRANE RECEPTOR; RANTES; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; CELL COUNT; CELL DESTRUCTION; CELL FUNCTION; CELL MIGRATION; CELL TRANSFORMATION; COMPLEX FORMATION; CYTOKINE RELEASE; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; EXOSOME; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MACROPHAGE; MEMBRANE MICROPARTICLE; MICROGLIA; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE ACTIVATION; TISSUE INJURY;

EID: 84930620930     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00111     Document Type: Review

References (76)

1. Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci (2005) 6:626-40. doi: 10.1038/nrn1722.
2. Schafer DP, Lehrman EK, Stevens B. The"quad-partite"synapse:microglia-synapse interactionsinthedevelopingandmature CNS. Glia (2013) 61:24-36. doi:10.1002/glia.22389.
3. Tremblay MÈ, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol (2010) 8:e1000527. doi:10.1371/journal.pbio.1000527.
4. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron (2012) 74:691-705. doi:10.1016/j.neuron.2012.03.026.
5. Roumier A, Bechade C, Poncer JC, Smalla KH, Tomasello E, Vivier E, et al. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J Neurosci (2004) 24:11421-8. doi:10.1523/JNEUROSCI.2251-04.2004.
6. Roumier A, Pascual O, Bechade C, Wakselman S, Poncer JC, Real E, et al. Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS One (2008) 3:e2595. doi:10.1371/journal.pone.0002595.
7. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science (2011) 333:1456-8. doi:10.1126/science.1202529.
8. Tremblay ME, Zettel ML, Ison JR, Allen PD, Majewska AK. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia (2012) 60:541-58. doi:10.1002/glia.22287.
9. Moriguchi S, Mizoguchi Y, Tomimatsua Y, Hayashia Y, Kadowaki T, Kagamiishi Y, et al. Potentiation of NMDA receptor-mediated synaptic responses by microglia. Mol Brain Res (2003) 119:160-9. doi:10.1016/j.molbrainres.2003.09.007.
10. Hayashi Y, Ishibashi H, Hashimoto K, Nakanishi H. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia (2006) 53:660-8. doi:10.1002/glia.20322.
11. Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA, et al. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci (2011) 31:16241-50. doi:10.1523/JNEUROSCI.3667-11.2011.
12. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature (2003) 424:778-83. doi:10.1038/nature01786.
13. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci (2005) 8:752-8. doi:10.1038/nn1472.
14. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature (2005) 438:1017-21. doi:10.1038/nature04223.
15. Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci U S A (2011) 109:197-205. doi:10.1073/pnas.1111098109.
16. Santos AR, Comprido D, Duarte CB. Regulation of local translation at the synapse by BDNF. Prog Neurobiol (2010) 92:505-16. doi:10.1016/j.pneurobio.2010.08.004.
17. Bianco F, Pravettoni E, Colombo A, Schenk U, Moller T, Matteoli M, et al. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol (2005) 174:7268-77. doi:10.4049/jimmunol.174.11.7268.
18. Antonucci F, Turola E, Riganti L, Caleo M, Gabrielli M, Perrotta C, et al. Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J (2012) 31:1231-40. doi:10.1038/emboj.2011.489.
19. Gabrielli M, Battista N, Riganti L, Prada I, Antonucci F, Cantone L, et al. Active endocannabinoids are secreted on extracellular membrane vesicles. EMBO Rep (2015) 16(2):213-20. doi:10.15252/embr.201439668.
20. Darios F, Wasser C, Shakirzyanova A, Giniatullin A, Goodman K, Munoz-Bravo JL, et al. Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis. Neuron (2009) 62:683-94. doi:10.1016/j.neuron.2009.04.024.
21. Kanno T, Nishizaki T, Proia RL, Kajimoto T, Jahangeer S, Okada T, et al. Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus. Neuroscience (2010) 171:973-80. doi:10.1016/j.neuroscience.2010.10.021.
22. Norman E, Cutler RG, Flannery R, Wang Y, Mattson MP. Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms. J Neurochem (2010) 114:430-9. doi:10.1111/j.1471-4159.2010.06779.x.
23. Raivich G, Banati R. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Rev (2004) 46:261-81. doi:10.1016/j.brainresrev.2004.06.006.
24. Mayo L, Quintana FJ, Weiner HL. The innate immune system in demyelinating disease. Immunol Rev (2012) 248:170-87. doi:10.1111/j.1600-065X.2012.01135.x.
25. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med (2005) 11:146-52. doi:10.1038/nm0405-455.
26. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol (1998) 161:3767-75.
27. Mildner A, Mack M, Schmidt H, Brück W, Djukic M, Zabel MD, et al. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain (2009) 132:2487-500. doi:10.1093/brain/awp144.
28. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med (2000) 192:899-905. doi:10.1084/jem.192.6.899.
29. Cagnin A, Kassiou M, Meikle SR, Banati RB. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics (2007) 4:443-52. doi:10.1016/j.nurt.2007.04.006.
30. Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology (2012) 79:523-30. doi:10.1212/WNL.0b013e3182635645.
31. Giunti D, Parodi B, Cordano C, Uccelli A, Kerlero de Rosbo N. Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. Immunology (2014) 141:328-39. doi:10.1111/imm.12177.
32. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res (1994) 38:365-75. doi:10.1002/jnr.490380402.
33. Lassmann H, Raine CS, Antel J, Prineas JW. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol (1998) 86:213-7. doi:10.1016/S0165-5728(98)00031-9.
34. Goldmann T, Prinz M. Role of microglia in CNS autoimmunity. Clin Dev Immunol (2013) 2013:208093. doi:10.1155/2013/208093.
35. Jiang Z, Jiang JX, Zhang GX. Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett (2014) 160:17-22. doi:10.1016/j.imlet.2014.03.006.
36. Aravalli RN, Hu S, Lokensgard JR. Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia. J Neuroinflammation (2007) 4:11. doi:10.1186/1742-2094-4-11.
37. Jack CS, Arbour N, Blain M, Meier UC, Prat A, Antel JP. Th1 polarization of CD4+ T cells by toll-like receptor 3-activated human microglia. J Neuropathol Exp Neurol (2007) 66:848-59. doi:10.1097/nen.0b013e3181492a7.
38. Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res (2002) 69:94-103. doi:10.1002/jnr.10253.
39. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol (2002) 61(11):1013-21.
40. Marta M, Meier UC, Lobell A. Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun Rev (2009) 8:506-9. doi:10.1016/j.autrev.2009.01.006.
41. Gandhi R, Laroni A, Weiner HL. Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol (2010) 221:7-14. doi:10.1016/j.jneuroim.2009.10.015.
42. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med (2005) 11:335-9. doi:10.1038/nm1202.
43. Duncan DS, Miller SD. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. PLoS One (2011) 6:e18548. doi:10.1371/journal.pone.0018548.
44. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, et al. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol (2007) 37:1290-301. doi:10.1002/eji.200636837.
45. Napoli I, Neumann H. Protective effects of microglia in multiple sclerosis. Exp Neurol (2010) 225:24-8. doi:10.1016/j.expneurol.2009.04.024.
46. Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain (2002) 125:75-85. doi:10.1093/brain/awf015.
47. Colombo E, Cordiglieri C, Melli G, Newcombe J, Krumbholz M, Parada LF, et al. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J Exp Med (2012) 209:521-35. doi:10.1084/jem.20110698.
48. Kotter MR, Zhao C, van Rooijen N, Franklin RJ. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis (2005) 18:166-75. doi:10.1016/j.nbd.2004.09.019.
49. Marzo L, Gousset K, Zurzolo C. Multifaceted roles of tunneling nanotubes in intercellular communication. Front Physiol (2012) 3:72. doi:10.3389/fphys.2012.00072.
50. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 9:581-93. doi:10.1038/nri2567.
51. Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol (2009) 21:575-81. doi:10.1016/j.ceb.2009.03.007.
52. Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine (2013) 44:11-9. doi:10.1007/s12020-012-9839-0.
53. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics (2010) 73:1907-20. doi:10.1016/j.jprot.2010.06.006.
54. Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol (2015) S0962-8924(15)00015-X. doi:10.1016/j.tcb.2015.01.004.
55. Chaput N, Thery C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol (2011) 33:419-40. doi:10.1007/s00281-010-0233-9.
56. Thery C. Exosomes: secreted vesicles and intercellular communications. F100 Biol Rep (2011) 3:15. doi:10.3410/B3-15.
57. Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol (2013) 113:1-11. doi:10.1007/s11060-013-1084-8.
58. Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, et al. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann Neurol (2012) 72:610-24. doi:10.1002/ana.23627.
59. Turola E, Furlan R, Bianco F, Matteoli M, Verderio C. Microglial microvesicles secretion and intercellular signaling. Front Physiol (2012) 3:149. doi:10.3389/fphys.2012.00149.
60. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia (2006) 20(9):1487-95. doi:10.1038/sj.leu.2404296.
61. Yuana Y, Sturk A, Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev (2013) 27:31-9. doi:10.1016/j.blre.2012.12.002.
62. Wheway J, Latham SL, Combes V, Grau GER. Endothelial microparticles interact with and support the proliferation of T cells. J Immunol (2014) 193:3378-87. doi:10.4049/jimmunol.1303431.
63. Saenz-Cuesta M, Osorio-Querejeta I, Otaegui D. Extracellular vesicles in multiple sclerosis: what are they telling us? Front Cell Neurosci (2014) 8:100. doi:10.3389/fncel.2014.00100.
64. Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, et al. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia (2010) 58:344-66. doi:10.1002/glia.20927.
65. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology (2001) 56:1319-24. doi:10.1212/WNL.56.10.1319.
66. Jy W, Minagar A, Jimenez JJ, Sheremata WA, Mauro LM, Horstman LL, et al. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci (2004) 9:3137-44. doi:10.2741/1466.
67. Barry OP, Pratico D, Savani RC, Fitzgerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest (1998) 102:136-44. doi:10.1172/JCI2592.
68. Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A. Evidence of platelet activation in multiple sclerosis. J Neuroinflammation (2008) 5:27. doi:10.1186/1742-2094-5-27.
69. Marcos-Ramiro B, Nacarino PO, Serrano-Pertierra E, Blanco-Gelaz MA, Weksler BB, Romero IA, et al. Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function. BMC Neurosci (2014) 15:110. doi:10.1186/1471-2202-15-110.
70. Prada I, Furlan R, Matteoli M, Verderio C. Classical and unconventional pathways of vesicular release in microglia. Glia (2013) 61(7):1003-17. doi:10.1002/glia.22497.
71. Scolding NJ, Morgan BP, Houston WA, Linington C, Campbell AK, Compston DA. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature (1989) 339:620-2. doi:10.1038/339620a0.
72. Jimenez J, Jy W, Mauro LM, Horstman LL, Ahn ER, Ahn YS, et al. Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Mult Scler (2005) 11(3):310-5. doi:10.1191/1352458505ms1184oa.
73. Sáenz-Cuesta M, Irizar H, Castillo-Triviño T, Muñoz-Culla M, Osorio-Querejeta I, Prada A, et al. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomark Med (2014) 8:653-61. doi:10.2217/bmm.14.9.
74. Sheremata WA, Jy W, Delgado S, Minagar A, McLarty J, Ahn Y. Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. J Neuroinflammation (2006) 3:23. doi:10.1186/1742-2094-3-23.
75. Lowery-Nordberg M, Eaton E, Gonzalez-Toledo E, Harris MK, Chalamidas K, McGee-Brown J, et al. The effects of high dose interferon-beta1a on plasma microparticles: correlation with MRI parameters. J Neuroinflammation (2011) 8:43. doi:10.1186/1742-2094-8-43.
76. Dawson G, Qin J. Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants. Biochem Biophys Res Commun (2011) 404:321-3. doi:10.1016/j.bbrc.2010.11.115.